Evaluating Chronic Pain Self-Management Support with an Opioid De-prescribing Intervention

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

October 28, 2020

Study Completion Date

October 28, 2020

Conditions
Chronic Pain
Interventions
BEHAVIORAL

Chronic Pain Self-Management Support

"Family physicians and nurse practitioners will participate in an academic detailing session with a pharmacist that focuses on safe, evidence-based opioid deprescribing. The pharmacist will provide pre-visit recommendations for each visit with a person on high doses of opioids. The pharmacist and healthcare providers will develop a patient centered, opioid taper schedule, with follow-up at 2 to 4 week intervals to assess for efficacy and safety.~The self-management intervention will be Chronic Pain Self-management Support with Pain Science Education and Exercise (COMMENCE), which consists of 2 visits per week over 6 weeks. One visit per week is 1.5 hours in a group format. with education about self-management and pain science as well as cognitive behavioural principles. The 2nd visit each week is 30 minutes in a one-to-one format and is individually tailored to support implementation of self-management plans and development of an exercise program."

Trial Locations (1)

K8N 2S9

Queen's Family Health Team, Belleville

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Queen's University

OTHER

NCT03890263 - Evaluating Chronic Pain Self-Management Support with an Opioid De-prescribing Intervention | Biotech Hunter | Biotech Hunter